en

PRODUCT DETAIL

BROXIVAN 3 mg/ml perorálny roztok

Code 8736D
MA number 52/0251/21-S
Product Form: sol por 1x125 ml/375 mg (fľ.skl.hnedá+plast.odmer.)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
Therapeutic Class: 52 - EXPECTORANTIA, MUCOLYTICA
ATC:
R RESPIRATORY SYSTEM
R05 COUGH AND COLD PREPARATIONS
R05C EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS
R05CB Mucolytics
R05CB06 Ambroxol
Shelf life: 24
Container: glass bottle
Route of admin.: Oral use
Prescription Status: Medicinal product not subject to medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 25.10.2021
Validity: 25.10.2026
Pediatric indication: Yes
Pediatric posology: Yes
Pediatric contraindication: Yes
Pediatric warnings: Yes
PIL: PIL_BROXIVAN 3 mg/ml perorálny roztok_12_2021.pdf  
SPC: SPC_BROXIVAN 3 mg/ml perorálny roztok_12_2021.pdf  
Safety feature No
Data update: 28.10.2021
eu-flag.png sk-flag.png